In a study involving nearly 1,000 patients seen at the Baltimore Convention Cent...
CLEVELAND — A recent study from researchers at University Hospitals (UH) Connor ...
CLEVELAND – Jeanne Lackamp, MD, DFAPA, FACLP, has been selected to serve as Chai...
A newly identified genetic marker could potentially predict which patients are l...
New York, NY – February 13, 2024 – The Mark Foundation for Cancer Research and t...
In the realm of biomedical sciences, the quest for accurate and efficient diagno...
Chemotherapy can save lives, but often a cancer patient may be resistant to thei...
Reston, VA—Peptide receptor radionuclide therapy (PRRT) is effective for clinica...
Living organisms often create what is needed for life from scratch. Credit: Phot...
Imagine your healthy child gets sick—so sick that you take them to the emergency...
Innovate UK has awarded £1m grant for a collaborative initiative called AI-VISIO...
The FDA granted breakthrough therapy status for J&J's nipocalimab for pregnant p...
Super Bowl LVIII saw Astellas run awareness for hot flashes and Pfizer touchdown...
The humanised monoclonal antibody DISC-3405 is under investigation in a Phase I ...
RadioMedix and Orano Med’s radioligand therapy AlphaMedix (lead-212-Dotamtate) i...
CSL’s post-MI drug failed to meet its primary endpoint of reducing the risk of m...
